Fever, Myalgias, and Weakness in a Patient with HIV

Published:February 27, 2022DOI:
      A 62-year-old Bolivian man residing in Spain since 2002, diagnosed with human immunodeficiency virus (HIV) infection in 2014 and with poor adherence to antiretroviral therapy (bictegravir/emtricitabine/tenofovir alafenamide), presented to the Emergency Department with 2-month history of asthenia, myalgias, and weakness. He complained of increased weakness and pain in his right arm, in addition to edema and distal paresthesia 10 days after he received the pneumococcal conjugate vaccine (Prevenar 13) in the same arm. His most recent CD4+ T-cell count was 174 cells/mL and he had a viral load of 114 copies/mL.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tehranzadeh J
        • Ter-Oganesyan RR
        • Seinbach LD
        Musculoskeletal disorders associated with HIV infection and AIDS. Part II: non-infectious musculoskeletal conditions.
        Skeletal Radiol. 2004; 33: 311-320
        • Tien-Auh Chan A
        • Kirton C
        • Estanislao L
        • Simpson DM
        Myopathy in HIV infection.
        Handb Clin Neurol. 2007; 85: 139-145
        • Spudich SS
        • Price RW
        Neurological disease.
        in: Dolin R Masur H Saag MS AIDS Therapy. 3rd ed. Churchill Livingstone, St. Louis2008: 1075-1101
        • Zandman-Goddard G
        • Shoenfeld Y
        HIV and autoimmunity.
        Autoimmun Rev. 2002; 1: 329-337
        • Lyons J
        • Venna N
        • Cho TA
        Atypical nervous system manifestations of HIV.
        Semin Neurol. 2011; 31: 254-265
        • Sellier P
        • Monsuez JJ
        • Evans J
        • et al.
        Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy.
        Am J Med. 2000; 109: 510-512
        • Dalakas MC
        Inflammatory, immune, and viral aspects of inclusion-body myositis.
        Neurology. 2006; 66: S33-S38
        • Gherardi R
        • Baudrimont M
        • Lionnet F
        • et al.
        Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study.
        Ann Neurol. 1992; 32: 535-542
        • Shah S
        • Danda D
        • Kavadichanda C
        • Das S
        • Adarsh MB
        • Negi VS
        Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.
        Rheumatol Int. 2020; 40: 1539-1554
        • Mammen AL
        Necrotizing myopathies: beyond statins.
        Curr Opin Rheumatol. 2014; 26: 679-683
        • Allenbach Y
        • Benveniste O
        • Stenzel W
        • Boyer O
        Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
        Nat Rev Rheumatol. 2020; 16: 689-701
        • Wrzolek MA
        • Sher JH
        • Kozlowski PB
        • Rao C
        Skeletal muscle pathology in AIDS: an autopsy study.
        Muscle Nerve. 1990; 13: 508-515
        • Liang C
        • Needham M
        Necrotizing autoimmune myopathy.
        Curr Opin Rheumatol. 2011; 23: 612-619
        • Mamarabadi M
        • Baisre A
        • Leitch M
        • Hsu V
        • Kanduri JS
        • Chen S
        Case of anti-single recognition particle-mediated necrotizing mmyopathy after influenza vaccination.
        J Clin Neuromuscul Dis. 2018; 19: 211-216
        • Cavalcanti JFB
        • Silva MBA
        • Alves de Siqueira Carvalho A
        Vaccination as a possible trigger for immune-mediated necrotising myopathy.
        BMJ Case Rep. 2021; 14e242095
        • Johnson RW
        • Williams FM
        • Kazi S
        • Dimachkie MM
        • Reveille JD
        Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome.
        Arthritis Rheum. 2003; 49: 172-178
        • Mammen AL
        • Tiniakou E
        Intravenous immune globulin for statin-triggered autoimmune myopathy.
        N Engl J Med. 2015; 373: 1680-1682
        • Allenbach Y
        • Mammen AL
        • Benveniste O
        • Stenzel W
        • Immune-Mediated Necrotizing Myopathies Working Group
        224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.
        Neuromuscul Disord. 2018; 28: 87-99